Acm Research, Inc. (ACMR) 10-K Annual Report March 2023

FREMONT, Calif., Feb. 24, 2023 (Globe Newswire) – ACM Research, Inc. (“ACM” or the “Company”) (NASDAQ: ACMR), a leading supplier of wafer processing solutions for semiconductor and advanced wafer-level packaging applications, today reported financial results for its fourth quarter and fiscal year ended December 31, 2022.

“2022 marks another year of progress on our mission to become a major supplier to the global semiconductor industry,” said ACM’s President and Chief Executive Officer, Dr. David Wang. “We delivered solid growth amidst COVID-related restrictions, supply-chain disruptions, and increased trade regulations. We believe that the pandemic is largely behind us, and we have returned to more normal operations.”

Dr. Wang continued, “Our results demonstrate the strength of ACM’s multi-product portfolio and our expanding customer base. We took share with our core cleaning products, more than doubled our revenue from ECP tools, and are achieving good traction with our furnace products. We also entered two new product categories with the introduction of the Ultra Pmax^TM PECVD and Ultra Lith^TM Track Coater/Developer tools, which we believe doubles our served addressable market. The evaluation of two cleaning tools at the U.S. facility of a major U.S.-based semiconductor manufacturer is going well, and we are pleased to announce an order for an evaluation tool to a major potential customer in Europe for delivery later this year.”

Dr. Wang concluded, “As we look ahead to 2023, we expect another year of growth driven by continued share gains, new products and new customers. We are on track to begin initial production at our new facility in Lingang, Shanghai in the second half of 2023, and we plan to increase our investments in Korea to support our international growth initiatives.”

	Three Months Ended December 31,
	GAAP						Non-GAAP(1)
	2022			2021			2022			2021
	(dollars in thousands, except EPS)
Revenue	$	108,542		$	95,142		$	108,542		$	95,142
Gross margin		49.6	%		47.8	%		49.7	%		47.9	%
Income from operations	$	16,670		$	19,126		$	19,164		$	20,420
Net income attributable to ACM Research, Inc.	$	11,809		$	15,565		$	12,596		$	18,069
Basic EPS	$	0.20		$	0.27		$	0.21		$	0.31
Diluted EPS (2)	$	0.18		$	0.23		$	0.19		$	0.27

	Year Ended December 31,
	GAAP						Non-GAAP(1)
	2022			2021			2022			2021
	(dollars in thousands, except EPS)
Revenue	$	388,832		$	259,751		$	388,832		$	259,751
Gross margin		47.2	%		44.2	%		47.4	%		44.4	%
Income from operations	$	59,035		$	38,702		$	66,765		$	43,819
Net income attributable to ACM Research, Inc.	$	39,263		$	37,757		$	54,848		$	42,267
Basic EPS	$	0.66		$	0.65		$	0.93		$	0.73
Diluted EPS (2)	$	0.59		$	0.58		$	0.83		$	0.65

(1)

Reconciliations to U.S. generally accepted accounting principles (“GAAP”) financial measures from non-GAAP financial measures are presented below under “Reconciliation of GAAP to Non-GAAP Financial Measures.” Non-GAAP financial measures exclude stock-based compensation and, with respect to net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share, also exclude unrealized loss on trading securities.

(2)	Prior period results have been adjusted to reflect the three-for-one stock split effected in the form of a stock dividend in March 2022.

Outlook

The Company is maintaining its revenue guidance range of $515 million to $585 million for fiscal year 2023. This expectation is based on ACM management’s current assessment of the potential impact from current US-China trade policy and together with various expected spending scenarios of key customers, supply chain constraints, and the timing of acceptances for first tools under evaluation in the field, among other factors.

Operating Highlights and Recent Announcements

•

Shipments. Total shipments in 2022 were $539 million, versus $372 million in 2021. Total shipments in the fourth quarter of 2022 were $197 million, versus $117 million in the fourth quarter of 2021. Total shipments include deliveries for revenue in the quarter and deliveries of first tool systems awaiting customer acceptance for potential revenue in future quarters.

•

Received Purchase Order for SAPS Tool from Major European Global Semiconductor Manufacturer. ACM announced the receipt of a first tool order for its Ultra C SAPS-V cleaning tool from a major Europe-based global semiconductor manufacturer. The tool is expected to be shipped to the prospective customer’s European facility in the fourth quarter of 2023.

•

First MLO-capable Ultra C pr Tool Qualified and in Mass Production at Power Semiconductor Manufacturer in China. ACM expanded its Ultra C pr product offering to include metal lift-off (MLO) capabilities for power semiconductor manufacturing and wafer level packaging (WLP) applications. MLO can be used to save an etch process step, reducing cost, optimizing cycle times and sharply reducing chemical demand at high temperatures. The first MLO-capable Ultra C pr tool has been qualified and released to mass production at a power semiconductor manufacturer in China.

•

Introduced Track Tool to Support Lithography for Semiconductor IC Manufacturing. ACM introduced its Ultra Lith^TM Track tool, marking its entry into the track market. ACM’s participation in this new product category is a natural evolution of its expertise in cleaning, coating and developing systems. The first Ultra Lith^TM Track Coater/Developer ArF tool was delivered to a domestic Chinese customer in the fourth quarter of 2022, an i-line model is planned for delivery in 2023, and ACM also has begun development of a KrF model.

•	Introduced PECVD Tool to Support Logic & Memory Manufacturing. ACM introduced its Ultra Pmax^TMPlasma-Enhanced Chemical Vapor Deposition (PECVD) tool as another major new product category, marking its entry into chemical vapor deposition (CVD) market.

Full Year 2022 Financial Summary

Unless otherwise noted, the following figures refer to the full year of 2022 and comparisons are with the full year of 2021.

•	Revenue was $388.8 million, up 49.7%, reflecting continued share gains by our flagship cleaning products and strong growth from our new products, particularly ECP tools.

•

Gross margin was 47.2%, up from 44.2%. Non-GAAP gross margin, which excludes stock-based compensation, was 47.4%, up from 44.4%. Gross margin exceeded the range of 40% to 45% reflected in the Company’s long-term business model. The Company expects gross margin to vary from period to period due to a variety of factors, such as sales volume, product mix and favorable currency impacts from a stronger dollar versus the Chinese RMB.

•

Operating expenses were $124.6 million, an increase of 63.6%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $117.4 million, up 64.3%. Operating expenses as a percent of revenue increased to 32.0% from 29.3%. Non-GAAP operating expenses as a percent of revenue increased to 30.2% from 27.5%.

•	Operating income was $59.0 million, up from $38.7 million. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $66.8 million, up from $43.8 million.

- 2 -

•

Unrealized loss on trading securities was $7.9 million. The loss reflects the change in market value of the indirect investment by ACM Shanghai in the STAR Market IPO shares of Semiconductor Manufacturing International Corporation (“SMIC”). The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.

•	Realized gain from sale of trading securities was $1.1 million due to the sale of a portion of ACM Shanghai’s shares of SMIC, which generated net proceeds of $4.5 million.

•

Income tax expense was $16.8 million, up from $0.1 million. As a result of a change in Section 174 of the U.S. Internal Revenue Code of 1986 that became effective on January 1, 2022, the effective tax rate for 2022 has increased, primarily due to a new requirement to capitalize and amortize previously deductible research and experimental expenses.

•

Net income attributable to ACM Research, Inc. was $39.3 million, compared to net income of $37.8 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $54.8 million, as compared to non-GAAP net income of $42.3 million.

•	Net income per diluted share attributable to ACM Research, Inc. was $0.59, compared to $0.58. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.83, compared to $0.65.

•	Cash and cash equivalents were $248.0 million at December 31, 2022, versus $336.3 million at September 30, 2022. Cash and cash equivalents, plus restricted cash and time deposits were $420.9 million at December 31, 2022, versus $473.2 million at September 30, 2022.

Fourth Quarter 2022 Financial Summary

Unless otherwise noted, the following figures refer to the fourth quarter of 2022 and comparisons are with the fourth quarter of 2021.

•	Revenue was $108.5 million, up 14.1%, reflecting continued share gains by our flagship cleaning products and contribution from our new products, particularly ECP tools.

•

Gross margin was 49.6%, up from 47.8%. Non-GAAP gross margin, which excludes stock-based compensation, was 49.7%, up from 47.9%. Gross margin exceeded the range of 40% to 45% reflected in the Company’s long-term business model. The Company expects gross margin to vary from period to period due to a variety of factors, such as sales volume, product mix and favorable currency impacts from a stronger dollar versus the Chinese RMB.

•

Operating expenses were $37.1 million, an increase of 41.1%. Non-GAAP operating expenses, which exclude the effect of stock-based compensation, were $34.8 million, up 38.4%. Operating expenses as a percent of revenue increased to 34.2% from 27.7%. Non-GAAP operating expenses as a percent of revenue increased to 32.0% from 26.4%.

•	Operating income was $16.7 million, down from $19.1 million. Non-GAAP operating income, which excludes the effect of stock-based compensation, was $19.2 million, down from $20.4 million.

•	Unrealized loss on trading securities was $1.7 million. The loss reflects the change in market value of the indirect investment by ACM Shanghai in the STAR Market IPO shares of SMIC. The value is marked-to-market quarterly and is excluded in the non-GAAP financial metrics.

•

Income tax expense was $2.7 million, compared to $3.2 million. As a result of a change in Section 174 of the U.S. Internal Revenue Code of 1986 that became effective on January 1, 2022, the effective tax rate for 2022 has increased, primarily due to a new requirement to capitalize and amortize previously deductible research and experimental expenses.

•

Net income attributable to ACM Research, Inc. was $11.8 million, compared to net income of $15.6 million. Non-GAAP net income attributable to ACM Research, Inc., which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $12.6 million, as compared to non-GAAP net income of $18.1 million.

•	Net income per diluted share attributable to ACM Research, Inc. was $0.18, compared to $0.23. Non-GAAP net income per diluted share, which excludes the effect of stock-based compensation and unrealized loss on trading securities, was $0.19, compared to $0.27.

- 3 -

Conference Call Details

A conference call to discuss results will be held on Friday, February 24, 2023, at 8:00 a.m. Eastern Time (9:00 p.m. China Time). To join the conference call via telephone, participants must use the following link to complete an online registration process. Upon registering, each participant will receive email instructions to access the conference call, including dial-in information and a PIN number allowing access to the conference call. This pre-registration process is designed by the operator to reduce delays due to operator congestion when accessing the live call.

Online Registration: https://register.vevent.com/register/BI8d1b21abbce04178b356565439642c73

Participants who have not pre-registered may join the webcast by accessing the link at ir.acmrcsh.com/events.

A live and archived webcast will be available on the Investors section of the ACM website at www.acmrcsh.com.

Use of Non-GAAP Financial Measures

ACM presents non-GAAP gross margin, operating expenses, operating income, net income (loss) attributable to ACM Research, Inc. and basic and diluted earnings per share as supplemental measures to GAAP financial measures regarding ACM’s operational performance. These supplemental measures exclude the impact of stock-based compensation, which ACM does not believe is indicative of its core operating results. In addition, non-GAAP net income attributable to ACM Research, Inc. and basic and diluted earnings per share exclude non-cash change in fair value of financial assets and liabilities and unrealized gain on trading securities, which ACM also believes are not indicative of its core operating results. A reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure is provided below under “Reconciliation of GAAP to non-GAAP Financial Measures.”

ACM believes these non-GAAP financial measures are useful to investors in assessing its operating performance. ACM uses these financial measures internally to evaluate its operating performance and for planning and forecasting of future periods. Financial analysts may focus on and publish both historical results and future projections based on the non-GAAP financial measures. ACM also believes it is in the best interests of investors for ACM to provide this non-GAAP information.

While ACM believes these non-GAAP financial measures provide useful supplemental information to investors, there are limitations associated with the use of these non-GAAP financial measures. These non-GAAP financial measures may not be reported by competitors, and they may not be directly comparable to similarly titled measures of other companies due to differences in calculation methodologies. The non-GAAP financial measures are not an alternative to GAAP information and are not meant to be considered in isolation or as a substitute for comparable GAAP financial measures. They should be used only as a supplement to GAAP information and should be considered only in conjunction with ACM’s consolidated financial statements prepared in accordance with GAAP.

Forward-Looking Statements

Certain statements contained in this press release are not historical facts and may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “plans,” “expects,” “believes,” “anticipates,” “designed,” and similar words are intended to identify forward-looking statements. Forward-looking statements are based on ACM management’s current expectations and beliefs, and involve a number of risks and uncertainties that are difficult to predict and that could cause actual results to differ materially from those stated or implied by the forward-looking statements. A description of certain of these risks, uncertainties and other matters can be found in filings ACM makes with the U.S. Securities and Exchange Commission, all of which are available at www.sec.gov. Because forward-looking statements involve risks and uncertainties, actual results and events may differ materially from results and events currently expected by ACM. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. ACM undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in its expectations with regard to these forward-looking statements or the occurrence of unanticipated events.

About ACM Research, Inc.

The Company develops, manufactures and sells semiconductor process equipment for single-wafer or batch wet cleaning, electroplating, stress-free polishing and thermal processes that are critical to advanced semiconductor device manufacturing, as well as wafer-level packaging. The Company is committed to delivering customized, high performance, cost-effective process solutions that semiconductor manufacturers can use in numerous manufacturing steps to improve productivity and product yield.

- 4 -

© ACM Research, Inc. ULTRA C and the ACM Research logo are trademarks of ACM Research, Inc. For convenience, these trademarks appear in this press release without ™ symbols, but that practice does not mean that ACM will not assert, to the fullest extent under applicable law, its rights to the trademarks.

For investor and media inquiries, please contact:

In the United States:	The Blueshirt Group
	Yujia Zhai
	+1 (860) 214-0809
	yujia@blueshirtgroup.com

In China:	The Blueshirt Group Asia
	Gary Dvorchak, CFA
	+86 (138) 1079-1480
	gary@blueshirtgroup.com

- 5 -

ACM RESEARCH, INC.

Condensed Consolidated Balance Sheets

	December 31, 2022			December 31, 2021
	(Unaudited)
	(In thousands, except for par value)
Assets
Current assets:
Cash and cash equivalents	$	247,951		$	562,548
Restricted cash		500			519
Short-term time deposits		70,492			-
Trading securities		20,209			29,498
Accounts receivable		182,936			105,553
Income tax receivable		-			1,082
Other receivables		29,617			18,979
Inventories		393,172			218,116
Advances to related party		3,322			2,383
Prepaid expenses		15,607			14,256
Total current assets		963,806			952,934
Property, plant and equipment, net		82,875			14,042
Land use right, net		8,692			9,667
Operating lease right-of-use assets, net		2,489			4,182
Intangible assets, net		1,255			477
Long-term time deposits		101,956			-
Deferred tax assets		6,703			13,166
Long-term investments		17,459			12,694
Other long-term assets		50,265			45,017
Total assets	$	1,235,500		$	1,052,179
Liabilities and Equity
Current liabilities:
Short-term borrowings	$	56,004		$	9,591
Current portion of long-term borrowings		2,322			2,410
Related party accounts payable		14,468			7,899
Accounts payable		101,735			93,451
Advances from customers		153,773			52,824
Deferred revenue		4,174			3,180
Income taxes payable		3,469			254
FIN-48 payable		6,686			2,282
Other payables and accrued expenses		52,201			31,735
Current portion of operating lease liability		1,382			2,313
Total current liabilities		396,214			205,939
Long-term borrowings		18,687			22,957
Long-term operating lease liability		1,107			1,869
Deferred tax liability		-			1,302
Other long-term liabilities		7,321			8,447
Total liabilities		423,329			240,514
Commitments and contingencies
Equity:
Stockholders’ equity:
Class A Common stock		5			5
Class B Common stock		1			1
Additional paid-in capital		604,089			595,045
Retained earnings		94,426			63,732
Statutory surplus reserve		16,881			8,312
Accumulated other comprehensive income (loss)		(40,546	)		9,109
Total ACM Research, Inc. stockholders’ equity		674,856			676,204
Non-controlling interests		137,315			135,461
Total equity		812,171			811,665
Total liabilities and equity	$	1,235,500		$	1,052,179

- 6 -

ACM RESEARCH, INC.

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

	Three Months Ended December 31,						Year Ended December 31,
	2022			2021			2022			2021
	(Unaudited) ( In thousands, except share and per share data)						(Unaudited) ( In thousands, except share and per share data)
Revenue	$	108,542		$	95,142		$	388,832		$	259,751
Cost of revenue		54,737			49,696			205,217			144,895
Gross profit		53,805			45,446			183,615			114,856
Operating expenses:
Sales and marketing		12,395			9,273			39,889			26,733
Research and development		17,835			12,914			62,226			34,207
General and administrative		6,905			4,133			22,465			15,214
Total operating expenses		37,135			26,320			124,580			76,154
Income from operations		16,670			19,126			59,035			38,702
Interest income		2,775			392			8,740			505
Interest expense		(669	)		(191	)		(1,655	)		(765	)
Realized gain from sale of trading securities		(20	)		-			1,116			-
Unrealized gain (loss) on trading securities		1,707			(1,210	)		(7,855	)		607
Other income (expense), net		(6,634	)		52			3,315			(631	)
Equity income in net income of affiliates		3,014			3,601			4,666			4,637
Income before income taxes		16,843			21,770			67,362			43,055
Income tax expense		(2,660	)		(3,155	)		(16,798	)		(134	)
Net income		14,183			18,615			50,564			42,921
Less: Net income attributable to non-controlling interests		2,374			3,050			11,301			5,164
Net income attributable to ACM Research, Inc.	$	11,809		$	15,565		$	39,263		$	37,757
Comprehensive income:
Net income		14,183			18,615			50,564			42,921
Foreign currency translation adjustment		21,232			3,436			(59,102	)		4,695
Comprehensive Income (loss)		35,415			22,051			(8,538	)		47,616
Less: Comprehensive income (loss) attributable to non-controlling interests and redeemable non-controlling interests		6,232			3,136			1,854			5,607
Comprehensive income (loss) attributable to ACM Research, Inc.	$	29,183		$	18,915		$	(10,392	)	$	42,009

Net income attributable to ACM Research, Inc. per common share:
Basic	$	0.20		$	0.27		$	0.66		$	0.65
Diluted	$	0.18		$	0.23		$	0.59		$	0.58

Weighted average common shares outstanding used in computing per share amounts:
Basic		59,268,562			58,588,386			59,235,975			57,654,708
Diluted		64,198,325			66,325,821			65,341,771			65,356,716

- 7 -

ACM RESEARCH, INC.

Total Revenue by Product Category, by Equipment Type and by Region

`	Three Months Ended December 31,				Year Ended December 31,
($ in thousand)	2022		2021		2022		2021
Single wafer cleaning, Tahoe and semi-critical cleaning equipment	$	74,603	$	61,886	$	272,939	$	189,208
ECP (front-end and packaging), furnace and other technologies		20,213		19,460		77,482		33,210
Advanced packaging (excluding ECP), services & spares		13,726		13,796		38,411		37,333
Total Revenue By Product Category	$	108,542	$	95,142	$	388,832	$	259,751

Wet cleaning and other front-end processing tools	$	79,333	$	74,946	$	308,528	$	202,268
Advanced packaging, other processing tools, services and spares		29,209		20,196		80,304		57,483
Total Revenue Front-end and Back-End	$	108,542	$	95,142	$	388,832	$	259,751

	Three Months Ended December 31,				Year Ended December 31,
	2022		2021		2022		2021
Mainland China	$	104,167	$	94,296	$	377,752	$	258,615
Other Regions		4,375		846		11,080		1,136
	$	108,542	$	95,142	$	388,832	$	259,751

- 8 -

ACM RESEARCH, INC.

Reconciliation of GAAP to Non-GAAP Financial Measures

As described under “Use of Non-GAAP Financial Measures” above, ACM presents non-GAAP gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share as supplemental measures to GAAP financial measures, each of which excludes stock-based compensation (SBC) from the equivalent GAAP financial line items. In addition, non-GAAP net income attributable to ACM Research, Inc., and basic and diluted earnings per share exclude unrealized gain on trading securities. The following table reconciles gross margin, operating expenses, operating income, net income attributable to ACM Research, Inc., and basic and diluted earnings per share to the related non-GAAP financial measures:

	Three Months Ended December 31,
	2022											2021
	Actual			SBC			Other non- operating adjustments		Adjusted			Actual			SBC			Other non- operating adjustments			Adjusted
	(GAAP)			SBC			Other non- operating adjustments		(Non-GAAP)			(GAAP)			SBC			Other non- operating adjustments			(Non-GAAP)
	(In thousands)

Revenue	$	108,542		$	-		$	-	$	108,542		$	95,142		$	-		$	-		$	95,142
Cost of revenue		(54,737	)		(137	)		-		(54,600	)		(49,696	)		(108	)		-			(49,588	)
Gross profit		53,805			(137	)		-		53,942			45,446			(108	)		-			45,554
Operating expenses:
Sales and marketing		(12,395	)		(600	)		-		(11,795	)		(9,273	)		(402	)		-			(8,871	)
Research and development		(17,835	)		(832	)		-		(17,003	)		(12,914	)		(314	)		-			(12,600	)
General and administrative		(6,905	)		(925	)		-		(5,980	)		(4,133	)		(470	)		-			(3,663	)
Income (loss) from operations	$	16,670		$	(2,494	)	$	-	$	19,164		$	19,126		$	(1,294	)	$	-		$	20,420
Unrealized gain (loss) on trading securities		1,707			-			1,707		-			(1,210	)		-			(1,210	)		-
Net income (loss) attributable to ACM Research, Inc.	$	11,809		$	(2,494	)	$	1,707	$	12,596		$	15,565		$	(1,294	)	$	(1,210	)	$	18,069
Basic EPS	$	0.20							$	0.21		$	0.27								$	0.31
Diluted EPS	$	0.18							$	0.19		$	0.23								$	0.27

	Year Ended December 31,
	2022												2021
	Actual			SBC			Other non- operating adjustments			Adjusted			Actual			SBC			Other non- operating adjustments		Adjusted
	(GAAP)			SBC			Other non- operating adjustments			(Non-GAAP)			(GAAP)			SBC			Other non- operating adjustments		(Non-GAAP)
	(In thousands)

Revenue	$	388,832		$	-		$	-		$	388,832		$	259,751		$	-		$	-	$	259,751
Cost of revenue		(205,217	)		(520	)		-			(204,697	)		(144,895	)		(397	)		-		(144,498	)
Gross profit		183,615			(520	)		-			184,135			114,856			(397	)		-		115,253
Sales and marketing		(39,889	)		(1,877	)		-			(38,012	)		(26,733	)		(1,802	)		-		(24,931	)
Research and development		(62,226	)		(2,565	)		-			(59,661	)		(34,207	)		(1,115	)		-		(33,092	)
General and administrative		(22,465	)		(2,768	)		-			(19,697	)		(15,214	)		(1,803	)		-		(13,411	)
Income from operations	$	59,035		$	(7,730	)	$	-		$	66,765		$	38,702		$	(5,117	)	$	-	$	43,819
Unrealized gain (loss) on trading securities		(7,855	)		-			(7,855	)		-			607			-			607		-
Net income (loss) attributable to ACM Research, Inc.	$	39,263		$	(7,730	)	$	(7,855	)	$	54,848		$	37,757		$	(5,117	)	$	607	$	42,267
Basic EPS	$	0.66								$	0.93		$	0.65							$	0.73
Diluted EPS	$	0.59								$	0.83		$	0.58							$	0.65

- 9 -

The following information was filed by Acm Research, Inc. (ACMR) on Friday, February 24, 2023 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/1680062/000114036123009508/brhc10048521_10k.htm

View differences made from one year to another to evaluate Acm Research, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Acm Research, Inc..

Continue

Assess how Acm Research, Inc.'s management team is paid from their Annual Proxy

Acm Research, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Rating
Learn More

Filter Sentiment:

All

Positive

Negative

Filter Category:

All

Financial

Revenue

M & A

Legal

Other

Filter Subcategory:

All

Earnings

Cash Flow

Expense

Product

Income

Geography

Other

Inside Acm Research, Inc.'s 10-K Annual Report:

Other - Other Highlight
A good or service is distinct if the customer can benefit from the good or service either on its own or together with other resources that are readily available to the customer, and the good or service is distinct in the context of the contract.

Financial - Earnings Highlight
The following table reconciles net income, the most directly comparable GAAP financial measure, to adjusted EBITDA: The $31.0 million increase in adjusted EBITDA for the year ended December 31, 2022 as compared to the year ended December 31, 2021 reflected higher income tax expense, an increase in unrealized loss on trading securities, an increase in net income, an increase in stock-based compensation, and an increase in depreciation and amortization, partly offset by a negative impact from an increase in interest income, net.
Financial - Cash Flow Highlight
We have presented shipments, adjusted EBITDA, free cash flow and adjusted operating income (loss) because they are key measures used by our management and board of directors to understand and evaluate our operating performance, to establish budgets and to develop operational goals for managing our business.
Financial - Earnings Highlight
We intend to retain all available funds and any future earnings to support the operation of and to finance the growth and development of our business and do not anticipate paying any cash dividends in the foreseeable future.
Financial - Expense Highlight
Research and development expense consists primarily of: compensation of personnel associated with our research and development activities, including stock-based compensation; costs of components and other research and development supplies; costs of tools built for product development purposes; travel expense associated with the research of technical requirements for product development purposes and testing of concepts under consideration; amortization of costs of software used for research and development purposes; and allocated overhead for rent and utilities.
Other - Other
Net cash used by operations...Read more
Financial - Cash Flow
Shipments, adjusted EBITDA, free cash...Read more
Revenue - Product
The table below represents the...Read more
Financial - Expense
Abnormal inventory costs such as...Read more
Financial - Earnings
We define "adjusted EBITDA" as...Read more
Financial - Expense
In particular, we believe that...Read more
Financial - Expense
General and administrative expense increased...Read more
Financial - Expense
As a result of the...Read more
M & A - Other
Risk Factors-Regulatory Risks-The PRC's currency...Read more
Revenue - Product
The increase in revenue for...Read more
Financial - Expense
We expect that, for the...Read more
Financial - Expense
General and administrative expense increased...Read more
Financial - Income
Interest and penalties related to...Read more
Other - Other
Promises in contracts which do...Read more
Other - Other
The SSP represents the price...Read more
Legal - Other
Further, on December 29, 2022,...Read more
Other - Other
Net cash provided by financing...Read more
Revenue - Product
Comparison of Years Ended December...Read more
Other - Other
The continuation of the COVID-19...Read more
Financial - Expense
Research and development expense increased...Read more
Revenue - Geography
Consistent with our methodology for...Read more
Financial - Earnings
The increased gross margin versus...Read more
Financial - Cash Flow
Free Cash Flow The following...Read more
Other - Other
Risk Factors-Risks Related to International...Read more
Legal - Other
Risk Factors" for a discussion...Read more
Revenue - Product
The unit of account for...Read more
Revenue - Product
Sales and Marketing Sales and...Read more
Revenue - Product
We utilize ASC 606 which...Read more
Revenue - Geography
The net proceeds of the...Read more
Financial - Income
On a quarterly basis, we...Read more
Revenue - Product
Revenue is recognized when we...Read more
Revenue - Product
Critical Accounting Policies and Estimates...Read more
Other - Other
We believe that the assumptions,...Read more
Revenue - Product
Risk Factors- Risks Related to...Read more
Other - Other
Our warranties are intended to...Read more
Other - Other
The significant change from the...Read more
Financial - Income
Other income (expense), net primarily...Read more
Financial - Income
The following tables reflect the...Read more
Financial - Earnings
Gross Margin We generally expect...Read more
Financial - Earnings
We expect gross margin to...Read more
Other - Other
Accordingly, we believe that these...Read more
Financial - Expense
Research and Development Research and...Read more
Other - Other
Estimates related to this item...Read more
Financial - Cash Flow
To the extent our cash...Read more
Financial - Income
Income Tax Benefit (Expense) We...Read more
Financial - Earnings
Gross margin decreased by 22...Read more
Financial - Income
Interest income (expense), net, Other...Read more
Revenue - Product
It is difficult to predict...Read more
Financial - Expense
Although stock-based compensation is an...Read more
Other - Other
ACM Shanghai was certified as...Read more
Revenue - Product
During the first six months...Read more
Revenue - Product
We have increased our sales...Read more
Other - Other
The $142.1 million decrease was...Read more
Other - Other
The product and customization services...Read more
Financial - Income
In accordance with the authoritative...Read more
Revenue - Product
Shipments consist of two components:...Read more
Revenue - Product
Sales and marketing expense can...Read more
Financial - Expense
Cost of Revenue and Gross...Read more
Revenue - Product
How We Evaluate Our Operations...Read more
M & A - Other
Projects: Our strategy includes a...Read more
Financial - Shares
Realized gain and unrealized loss...Read more
Other - Other
Fluctuations vary depending on cash...Read more
Other - Other
We provide an allowance for...Read more
Other - Other
However, whether the PCAOB will...Read more
Financial - Income
Government subsidies related to depreciable...Read more
Financial - Earnings
Net Income Attributable to Non-Controlling...Read more
Financial - Earnings
Net Income Attributable to Non-Controlling...Read more
Other - Other
The following summary reflects our...Read more
Other - Other
We actively manage our operations...Read more
Other - Other
The dollar amount attributed to...Read more
Other - Other
The impact of fluctuations of...Read more
Revenue - Product
We expect that the period...Read more
Other - Other
A contract contains a promise...Read more
Other - Other
The total cumulative investment of...Read more
Financial - Shares
Upon completion of the STAR...Read more
Financial - Expense
Our manufacturing overhead standards for...Read more
Other - Other
Risk Factors-Risks Related to Our...Read more
Financial - Shares
The increased demand from PRC-based...Read more
Financial - Income
For the years ended December...Read more
Other - Other
The policies began with an...Read more
Revenue - Product
Revenue from contracts with customers...Read more
Other - Other
The extent to which COVID-19...Read more
Financial - Income
The increase in our effective...Read more
Financial - Income
Those adjustments may materially affect...Read more
Financial - Shares
Equity income in net income...Read more
Other - Other
As a result, we may...Read more

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Material Contracts, Statements, Certifications & more

Acm Research, Inc. provided additional information to their SEC Filing as exhibits

Exhibit 4.05: Instruments Defining The Rights Of Security Holders, Including Indentures

Exhibit 21.01: Subsidaries Of The Registrant

Exhibit 23.01: Consents Of Experts And Counsel

Exhibit 23.02: Consents Of Experts And Counsel

Exhibit 31.01: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 31.02: Rule 13A-14(A)/15D-14(A) Certification

Exhibit 32.01: Section 1350 Certification

Exhibit 99.01: Additional Exhibits

Ticker: ACMR
CIK: 1680062
Form Type: 10-K Annual Report
Accession Number: 0001140361-23-009508
Submitted to the SEC: Wed Mar 01 2023 7:37:12 PM EST
Accepted by the SEC: Thu Mar 02 2023
Period: Saturday, December 31, 2022
Industry: Special Industry Machinery